Shi-Yong Sun

20PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemical thermodynamics and energeticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 30, 2026
Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer.

|Apr 17, 2025
Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells.

You-Take Oh, Zhen Chen, Dongsheng Wang

|Feb 13, 2025
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer.

Guojing Zhang, Abbe Pannucci, Andrey A Ivanov

|Sep 19, 2024
Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer.

Zhen Chen, Karin A Vallega, Dongsheng Wang

|Sep 03, 2024
SHP2 ablation mitigates osteoarthritic cartilage degeneration by promoting chondrocyte anabolism through SOX9.

Lijun Wang, Huiliang Yang, Changwei Wang

|Jul 24, 2024
Targeting Transient Receptor Potential Melastatin-2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer.

Zhen Chen, Karin A Vallega, Vijay K Boda

Pageof 4

Frequent Collaborators

7 joint publications

Suresh S Ramalingam

4 joint publications

Taofeek K Owonikoko

2 joint publications

Songqing Fan

2 joint publications

Karin A Vallega